The dosage unit sampling apparatus market is expected to reach US$ 2.71 Billion in 2022, growing at a Y-o-Y rate of 8% from 2021. In 2021, the market was valued at US$ 2.5 Billion and is expected to register a CAGR of 8.3% to reach US$ 6 Billion.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 2.50 Billion |
| Expected Market Value (2022) | US$ 2.71 Billion |
| Anticipated Forecast Value (2032) | US$ 6 Billion |
| Projected Growth Rate (2022 to 2032) | 8.3% CAGR |
Dose uniformity is an important quality attribute to consider when determining the safety, quality, and efficacy of an inhaled and oral nasal drug. The dosage unit sampling apparatus is a device used to analyze the amount or dose delivered as well as the total amount of drug released from the inhaler in dry powder inhalers (DPIs) and metered dose inhalers (MDIs), and thus the amount available to the user.
Rising levels of air pollution, as well as occupational respiratory hazards. For a decade, inhalation-based treatment for respiratory diseases has been known, and advancements in inhalers and dosage unit sampling apparatus have increased treatment efficiency. Metered-dose inhalers (MDI) and dry powder inhalers (DPI) are the most commonly used inhalation treatments today.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Tobacco smoking, whether active or passive, has increased globally and is regarded as the leading cause of the chronic obstructive pulmonary disease (COPD). COPD prevalence was reported to be more than 251 million in the historical period, according to WHO's Global Disease Burden Statistics. COPD is a chronic disease that begins with breathing difficulties and progresses to exacerbation and serious life-threatening illness.
COPD incidences are expected to rise due to rising tobacco smoking prevalence and an aging population, which is likely to increase the use of inhalers, which will increase the use of dosage unit sampling apparatus during the review period. Because of the foregoing, an increase in demand for dry powder inhalers is expected to boost demand for dosage unit sampling apparatus during the forecast period.
The growing geriatric population around the world is expected to indirectly drive demand for dosage unit sampling apparatus, as the risk of respiratory disease is higher in the elderly. Between 2000 and 2050, the geriatrics population is expected to grow from 606 million to 3 billion, accounting for 12% to 23% of the total population.
Except for the Asia Pacific Because of rapid industrialization, which is transforming the manufacturing sector in emerging geographies such as India and China, Japan is expected to register the fastest growth in the global Dosage Unit Sampling Apparatus market.
During the forecast period, the Asia-Pacific metered-dose inhaler market is expected to grow at a significant rate of around 5%. A large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region are major factors boosting the market growth.
Principal Consultant
According to the CDC, COPD was the third leading cause of death in the United States, with a prevalence of nearly 15 million over the historical period. Furthermore, respiratory diseases are the leading cause of hospitalization and emergency room visits for children in North America. As a result of the foregoing, the North American market for Dosage Unit Sampling Apparatus is expected to account for a sizable share during the forecast period.
The dosage unit sampling apparatus market is highly fragmented, with both global and regional players present. Some of the prominent players in global dosage unit sampling apparatus market are Copley scientific, 3M, ERWEKA, Analytical Technologies Pte Ltd.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.3% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, End Use Application, Distribution Channel, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Mexico, Brazil, Germany, UK, France, Spain, Italy, Poland, Russia, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Copley Scientific; 3M; ERWEKA; Analytical Technologies Pte Ltd. |
| Customization | Available Upon Request |
FMI projects the global Dosage Unit Sampling Apparatus market to expand at a 8.3% value CAGR by 2032
Asia Pacific is expected to be the most opportunistic Dosage Unit Sampling Apparatus market, expanding at a 5% CAGR
Copley scientific, 3M, ERWEKA, Analytical Technologies Pte Ltd. are some prominent dosage unit sampling apparatus manufacturers.
Explore Testing Equipment Insights
View Reports
Dosage Unit Sampling Apparatus Market
